168 related articles for article (PubMed ID: 6170517)
1. Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. I. Specificity and HLA restriction of effector cells reactivated in vitro.
Moss DJ; Wallace LE; Rickinson AB; Epstein MA
Eur J Immunol; 1981 Sep; 11(9):686-93. PubMed ID: 6170517
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. II. Blocking studies with monoclonal antibodies to HLA determinants.
Wallace LE; Moss DJ; Rickinson AB; McMichael AJ; Epstein MA
Eur J Immunol; 1981 Sep; 11(9):694-9. PubMed ID: 6271557
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. III. Establishment of HLA-restricted cytotoxic T cell lines using interleukin 2.
Wallace LE; Rowe M; Gaston JS; Rickinson AB; Epstein MA
Eur J Immunol; 1982 Dec; 12(12):1012-8. PubMed ID: 6297919
[TBL] [Abstract][Full Text] [Related]
4. Multiple HLA class I-dependent cytotoxicities constitute the "non-HLA-restricted" response in infectious mononucleosis.
Strang G; Rickinson AB
Eur J Immunol; 1987 Jul; 17(7):1007-13. PubMed ID: 2440688
[TBL] [Abstract][Full Text] [Related]
5. Reactivation of Epstein-Barr virus-specific cytotoxic T cells by in vitro stimulation with the autologous lymphoblastoid cell line.
Rickinson AB; Moss DJ; Allen DJ; Wallace LE; Rowe M; Epstein MA
Int J Cancer; 1981 May; 27(5):593-601. PubMed ID: 6169663
[TBL] [Abstract][Full Text] [Related]
6. Analysis of cellular immune response to EBV by using cloned T cell lines.
Slovin SF; Schooley RT; Thorley-Lawson DA
J Immunol; 1983 May; 130(5):2127-32. PubMed ID: 6187840
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of allogeneic restriction of human cytotoxic T cell clones specific for Epstein Barr virus.
Tanaka Y; Sugamura K; Hinuma Y
J Immunol; 1982 Mar; 128(3):1241-5. PubMed ID: 6173428
[TBL] [Abstract][Full Text] [Related]
8. Memory of Epstein-Barr virus-specific cytotoxic T cells in normal seropostive adults as revealed by an in vitro restimulation method.
Tanaka Y; Sugamura K; Hinuma Y; Sato H; Okochi K
J Immunol; 1980 Oct; 125(4):1426-31. PubMed ID: 6157733
[TBL] [Abstract][Full Text] [Related]
9. In vitro induction of HLA-restricted cytotoxic T lymphocytes against autologous Epstein-Barr Virus transformed B lymphoblastoid cell line.
Fukukawa T; Hirano T; Sakaguchi N; Teranishi T; Tsuyuguchi I; Nagao N; Naito N; Yoshimura K; Okubo Y; Tohda H; Oikawa A
J Immunol; 1981 May; 126(5):1697-701. PubMed ID: 6163815
[TBL] [Abstract][Full Text] [Related]
10. Stimulation with autologous lymphoblastoid cell lines: lysis of Epstein-Barr virus-positive and -negative cell lines by two phenotypically distinguishable effector cell populations.
Zarling JM; Dierckins MS; Sevenich EA; Clouse KA
J Immunol; 1981 Nov; 127(5):2118-23. PubMed ID: 6170690
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the in vitro outgrowth of Epstein-Barr virus-transformed lymphocytes by thymus-dependent lymphocytes from infectious mononucleosis patients.
Rickinson AB; Crawford D; Epstein MA
Clin Exp Immunol; 1977 Apr; 28(1):72-9. PubMed ID: 193663
[TBL] [Abstract][Full Text] [Related]
12. Establishment of human cytotoxic T cell lines specific for human adult T cell leukemia virus-bearing cells.
Kannagi M; Sugamura K; Sato H; Okochi K; Uchino H; Hinuma Y
J Immunol; 1983 Jun; 130(6):2942-6. PubMed ID: 6189906
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the T cell-mediated cellular cytotoxicity during acute infectious mononucleosis.
Tomkinson BE; Maziarz R; Sullivan JL
J Immunol; 1989 Jul; 143(2):660-70. PubMed ID: 2472449
[TBL] [Abstract][Full Text] [Related]
14. Human T-cell hybrids with HLA-restricted proliferative response to Epstein-Barr virus-infected B cells.
Gallagher G; Stimson WH
Immunology; 1984 Dec; 53(4):611-21. PubMed ID: 6209205
[TBL] [Abstract][Full Text] [Related]
15. Multiple epitopes on human and murine cells expressing HLA-B7 as defined by specific murine cytotoxic T cell clones.
Yannelli JR; Moore LC; Engelhard VH
J Immunol; 1985 Aug; 135(2):900-5. PubMed ID: 2409157
[TBL] [Abstract][Full Text] [Related]
16. Recognition of Epstein-Barr virus (EBV)-infected cells by T cell colonies from a human chimera: restriction by allogeneic determinants.
Plotnicky H; Touraine JL
Clin Exp Immunol; 1993 Dec; 94(3):494-9. PubMed ID: 7504600
[TBL] [Abstract][Full Text] [Related]
17. Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity.
Burrows SR; Silins SL; Khanna R; Burrows JM; Rischmueller M; McCluskey J; Moss DJ
Eur J Immunol; 1997 Jul; 27(7):1726-36. PubMed ID: 9247584
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the growth of Epstein-Barr virus-infected B cells. I. Growth regression by E rosetting cells from VCA-positive donors is a combined effect of autologous mixed leukocyte reaction and activation of T8+ memory cells.
Konttinen YT; Bluestein HG; Zvaifler NJ
J Immunol; 1985 Apr; 134(4):2287-93. PubMed ID: 2857749
[TBL] [Abstract][Full Text] [Related]
19. Lymphocyte transformation induced by autologous cells. III. Lymphoblast-induced lymphocyte to stimulation does not correlate with EB viral antigen expression or immunity.
Weksler ME
J Immunol; 1976 Feb; 116(2):310-4. PubMed ID: 55437
[TBL] [Abstract][Full Text] [Related]
20. Lysis of allogeneic human lymphocytes by nonspecifically activated T-like cells.
McMichael AJ; Gotch FM; Hildreth JE
Eur J Immunol; 1982 Dec; 12(12):1002-5. PubMed ID: 6984389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
